A Molecular Hepatocellular Carcinoma Prognostic Score System Precisely Predicts Overall Survival of Hepatocellular Carcinoma Patients
Open Access
- 20 August 2021
- journal article
- research article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 10 (2), 273-283
- https://doi.org/10.14218/jcth.2021.00010
Abstract
With high rates of recurrence post-treatment, hepatocellular carcinoma (HCC) is one of the most common types of cancer worldwide and the major cause of cancer death. To improve the overall survival of HCC patients, identification of a reliable biomarker and precise early diagnosis of HCC remain major unsolved problems.Keywords
This publication has 41 references indexed in Scilit:
- Mitochondrial metabolism in the noncancerous liver determine the occurrence of hepatocellular carcinoma: a prospective studyThe Esophagus, 2013
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced CancerThe New England Journal of Medicine, 2012
- Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinomaHepatology, 2011
- A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma PatientsCancer Research, 2010
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNMAnnals of Surgical Oncology, 2010
- Prognostic Models With Competing RisksEpidemiology, 2009
- How To Build and Interpret a Nomogram for Cancer PrognosisJournal of Clinical Oncology, 2008
- Classification and prediction of survival in hepatocellular carcinoma by gene expression profilingHepatology, 2004
- Expression profiling and identification of novel genes in hepatocellular carcinomasOncogene, 2001
- Prognosis of Hepatocellular Carcinoma: The BCLC Staging ClassificationSeminars in Liver Disease, 1999